Phase II trial from per week irinotecan/cisplatin in advanced esophageal malignant tumors Di Lauro L, Fattoruso Au moment ou, Giacinti L, ainsi que al. Second-line chemo that have FOLFIRI in the patients with metastatic gastric
Phase II trial from per week irinotecan/cisplatin in advanced esophageal malignant tumors Di Lauro L, Fattoruso Au moment ou, Giacinti L, ainsi que al. Second-line chemo that have FOLFIRI in the patients with metastatic gastric